Pillar Clinical Research Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Pillar Clinical Research's estimated annual revenue is currently $6.3M per year.(i)
  • Pillar Clinical Research's estimated revenue per employee is $91,800

Employee Data

  • Pillar Clinical Research has 69 Employees.(i)
  • Pillar Clinical Research grew their employee count by 57% last year.

Pillar Clinical Research's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Experience OfficerReveal Email/Phone
5
VP Training and DevelopmentReveal Email/Phone
6
VP Clinical AffairsReveal Email/Phone
7
Director Corporate DevelopmentReveal Email/Phone
8
Site Director/Psychometric RaterReveal Email/Phone
9
Site DirectorReveal Email/Phone
10
Director RecruitingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M36-16%N/AN/A
#2
$6M6514%N/AN/A
#3
$1.8M250%N/AN/A
#4
$6.5M6629%N/AN/A
#5
$1.5M21-12%N/AN/A
#6
$2.5M31-3%N/AN/A
#7
$1.7M2433%N/AN/A
#8
$2.7M33-11%N/AN/A
#9
$8.5M8320%N/AN/A
#10
$40.9M32111%N/AN/A
Add Company

What Is Pillar Clinical Research?

Pillar Clinical Research, LLC provides expert & experienced conduct of Phase 1-4 clinical trials for both inpatient and outpatient studies. We are a multi-specialty clinical research group, with specialization in CNS indications: such as, but not limited to, schizophrenia, mood & anxiety disorders, PTSD, post-partum depression, addictions.

keywords:N/A

N/A

Total Funding

69

Number of Employees

$6.3M

Revenue (est)

57%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pillar Clinical Research News

2022-04-17 - $20M IHMC research facility could connect Pensacola's historic and downtown districts

$20M IHMC research facility could connect Pensacola's historic and ... That new pillar would mean the staff could study things such as how...

2022-04-17 - A Wealth of Clinical Trials Pushes the Treatment Landscape ...

Carbone: [Immunotherapy] represents a new pillar of therapy available for treating patients with lung cancer. It started out in the second-...

2022-04-06 - Pillar Biosciences Presents New Clinical Validation Data ...

“Results of the validation study of Pillar's oncoReveal™ Dx Lung & Colon Cancer Assay established that this FDA-approved IVD assay can...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9M69-9%N/A
#2
$9M69-1%N/A
#3
$15M7019%N/A
#4
$9.1M7035%N/A
#5
$9.1M7035%N/A